Financial results - CHANGNING DEKANG BIOTECHNOLOGY SRL

Financial Summary - Changning Dekang Biotechnology Srl
Unique identification code: 30099411
Registration number: J23/1074/2012
Nace: 2059
Sales - Ron
269.095
Net Profit - Ron
-293.516
Employees
12
Open Account
Company Changning Dekang Biotechnology Srl with Fiscal Code 30099411 recorded a turnover of 2024 of 269.095, with a net profit of -293.516 and having an average number of employees of 12. The company operates in the field of Fabricarea altor produse chimice n.c.a. having the NACE code 2059.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Changning Dekang Biotechnology Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 56.944 136.753 356.351 426.757 471.031 352.744 465.197 392.605 329.580 269.095
Total Income - EUR 138.596 254.018 502.208 468.370 544.242 514.665 558.024 562.634 531.209 363.372
Total Expenses - EUR 383.581 373.203 385.803 450.866 509.399 389.503 641.234 613.319 758.397 649.716
Gross Profit/Loss - EUR -244.985 -119.185 116.405 17.504 34.843 125.162 -83.209 -50.685 -227.188 -286.344
Net Profit/Loss - EUR -246.740 -119.928 105.831 13.229 30.126 121.117 -87.863 -54.511 -230.707 -293.516
Employees 24 24 22 25 26 21 16 14 13 12
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -17.9%, from 329.580 euro in the year 2023, to 269.095 euro in 2024.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Changning Dekang Biotechnology Srl

Rating financiar

Financial Rating -
CHANGNING DEKANG BIOTECHNOLOGY...

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Changning Dekang Biotechnology...

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Changning Dekang Biotechnology...

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Changning Dekang Biotechnology...

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Changning Dekang Biotechnology Srl - CUI 30099411

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 523.905 498.179 487.879 456.248 431.616 415.200 383.059 368.224 392.666 418.104
Current Assets 176.602 245.375 278.966 296.723 357.556 369.539 374.942 567.122 346.180 319.662
Inventories 54.490 110.749 145.386 115.670 146.948 176.961 209.830 334.803 196.081 193.675
Receivables 86.929 93.666 114.024 113.733 122.409 143.387 67.332 84.754 92.947 113.817
Cash 35.182 40.960 19.555 67.320 88.198 49.192 97.780 147.565 57.152 12.170
Shareholders Funds -495.604 -610.477 -494.316 -471.585 -432.327 -303.014 -384.158 -439.861 -669.234 -959.010
Social Capital 2.250 2.227 2.189 2.579 2.529 2.481 2.426 2.433 2.426 2.412
Debts 1.196.396 1.354.590 1.261.897 1.225.457 1.222.493 1.089.159 1.143.151 1.374.656 1.408.164 1.695.770
Income in Advance 0 0 0 0 0 0 0 2.056 1.281 2.124
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "2059 - 2059"
CAEN Financial Year 2059
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 319.662 euro in 2024 which includes Inventories of 193.675 euro, Receivables of 113.817 euro and cash availability of 12.170 euro.
The company's Equity was valued at -959.010 euro, while total Liabilities amounted to 1.695.770 euro. Equity decreased by -293.516 euro, from -669.234 euro in 2023, to -959.010 in 2024. The Debt Ratio was 229.5% in the year 2024.

Risk Reports Prices

Reviews - Changning Dekang Biotechnology Srl

Comments - Changning Dekang Biotechnology Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.